Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 17/20 | 0.57 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.57 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.57 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.57 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.57 |
| ▸ | PI4KA | P42356 | 3/20 | 0.43 |
| ▸ | PIK3R1 | P27986 | 5/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL661037 | 1.00 | PIK3CA (0.57) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL21087321 | 0.93 | PIK3CA (0.49) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL457631 | 0.92 | PIK3CA (0.48) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL17255826 | 0.91 | PIK3CA (0.48) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL458224 | 0.90 | PIK3CD (0.67) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL15049941 | 0.90 | PIK3CD (0.67) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL659369 | 0.89 | PIK3CA (0.55) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL23171066 | 0.87 | PIK3CA (0.48) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL17255828 | 0.84 | PIK3CA (0.80) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB | |
| SCHEMBL470153 | 0.84 | PIK3CA (0.80) | PIK3CAPIK3CGPIK3CDPIK3R2PIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2613781-A1 | INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012032065-A1 | INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION | GLAXO GROUP LIMITED (GB) | 2012-03-15 | — | — | WO | disclosed |